Kelly Gast, MD

Saint Luke's has been a cornerstone of health care in the community for 140 years, employing 13,000 individuals and showcasing a commitment to excellent benefits, kindness, and diversity. As a part of the BJC Health System, they strive to deliver high-quality health care to all, supported by a long history of innovation and community service. In addition to a wide range of medical services, including hospitals, clinics, and specialized care options, Saint Luke's is dedicated to providing educational resources and volunteer opportunities. Their philanthropic efforts, highlighted by the Saint Luke's Foundation, aim to enhance access to care and improve the well-being of the community. Generated from the website

Whitney Hensing, MD, is a fellowship-trained and board-certified hematology oncologist. Dr Hensing develops a personalized plan to fit each patient’s specific breast cancer, medical history, and treatment goals. During her fellowship at Washington University and Siteman Cancer Center, Dr Hensing developed a multicenter phase 1 clinical trial using a unique drug combination in patients with HER2 altered tumors. She was awarded the Young Investigator Award in breast cancer disparities research from the ASCO Conquer Cancer Foundation. Dr Hensing’s clinical interests include clinical trials and developing new targeted therapies for patients with breast cancer.

Addison Tolentino, MD, is a board-certified oncologist and hematologist with Saint Luke's Cancer Specialists. His areas of interests include gastroenterologic malignancies, pancreatic and breast cancers, genitourinary cancers, lymphomas and non-malignant disorders.